VASO logo

Vaso Corporation Stock Price

OTCPK:VASO Community·US$31.7m Market Cap
  • 0 Narratives written by author
  • 0 Comments on narratives written by author
  • 2 Fair Values set on narratives written by author

VASO Share Price Performance

US$0
-0.12 (-100.00%)
US$0
-0.12 (-100.00%)
Price US$0

VASO Community Narratives

There are no narratives available yet.

Trending Discussion

Updated Narratives

No recently updated narratives available.

Snowflake Analysis

Flawless balance sheet and good value.

2 Risks
2 Rewards

Vaso Corporation Key Details

US$89.1m

Revenue

US$34.8m

Cost of Revenue

US$54.3m

Gross Profit

US$51.7m

Other Expenses

US$2.6m

Earnings

Last Reported Earnings
Sep 30, 2025
Next Reporting Earnings
n/a
0.015
60.91%
2.91%
1.0%
View Full Analysis

About VASO

Founded
1987
Employees
298
CEO
Jun Ma
WebsiteView website
vasocorporation.com

Vaso Corporation, together with its subsidiaries, operates in the healthcare equipment and information technology industries in the United States and internationally. It operates in three segments: IT, Professional Sales Service, and Equipment. The IT segment primarily focuses on healthcare IT and managed network technology services. This segment offers managed healthcare software solutions, including diagnostic imaging applications; managed network infrastructure, such as routers, switches, and other equipment; managed network transport; and managed network security services. The Professional Sales Service segment principally focuses on the sale of healthcare capital equipment for General Electric Healthcare, Inc. (GEHC) into the health provider middle market. Its offerings include GEHC diagnostic imaging equipment and ultrasound systems, GEHC service agreements, GEHC training, and GEHC and third-party financial services. The Equipment segment primarily focuses on the design, manufacture, sale, and service of proprietary medical devices and software. This segment offers Biox series Holter monitors and ambulatory blood pressure recorders; ARCS series analysis, reporting, and communication software for ECG and blood pressure signals, including cloud-based software and algorithm subscription services; MobiCare multi-parameter wireless vital-sign monitoring systems; and Enhanced External Counterpulsation therapy systems for non-invasive and outpatient treatment of ischemic heart disease. The company was formerly known as Vasomedical, Inc. and changed its name to Vaso Corporation in November 2016. Vaso Corporation was incorporated in 1987 and is headquartered in Plainview, New York.

Recent VASO News & Updates

Recent updates

No updates